CTRI/2009/091/001078
Recruiting
Phase 3
Randomised , triple blinded, placebo controlled, clinical trial to compare the effect of Ketorolac tromethamine 0.4% in prophylactically preventing Cystoid Macula Edema following Cataract Surgery
I0 sites704 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- I
- Enrollment
- 704
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult males and females 50\-70 years of age coming for cataract surgery to our hospital.
- •Staying within 40 kms of Vellore town.
Exclusion Criteria
- •Inabiltity to visualise the macula preoperatively in the eye to be operated.
- •Ocular disease that can affect macular function.
- •Uncontrolled Diabetics defined by RBS/PP Sugars \> 200mg/dl.
- •Diabetic Maculopathy with Edema in eye to be operated.
- •Past History of intraocular surgery in the eye under consideration.
- •History of use of Topical steroid drops or NSAID drops within the past 30 days prior to enrolment.
- •Current use of Oral steroids.
- •Known NSAIDs Allergy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.EUCTR2008-002264-34-LTETI Pharma GmbH210
Active, not recruiting
Phase 1
Randomised, double blinded, placebo controlled, parallel group study to evaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients with allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma.EUCTR2008-002264-34-PLETI Pharma GmbH210
Active, not recruiting
Not Applicable
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.EUCTR2008-002264-34-DEETI Pharma GmbH210
Active, not recruiting
Not Applicable
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitisation against grass pollen AND birch pollen.MedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039095Term: Rhinitis seasonalEUCTR2008-002264-34-BGETI Pharma GmbH210
Completed
Not Applicable
Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma PatientsDiseases of th respiratory systemKCT0000571Sama Pharm234